[1] | Agnello V and De-Rosa FG., (2004): Extra-hepatic disease manifestations of HCV infection: some current issues. J. Hepatol; 40: 341 - 452. |
[2] | Agnello V, Chung RT and Kaplan LM., (1992): A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med; 327: 1490 - 1495. |
[3] | Alberti A and Benvegnu L., (2003): Management of hepatitis C. J Hepatol 38 (Suppl. 1): S104 - 118. |
[4] | Aliannejad R, and Ghanei M., (2011): Hepatitis C and Pulmonary fibrosis Hepatitis Monthly;11(2): 71 - 73. |
[5] | American Thoracic Society, European Respiratory society (2002): American Thoracic society\European Respiratory society International Multidisciplinary consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS) And European Respiratory Society (ERS) Was Adopted By the ATS Board Of Direction, JUNE 2001 And By ERS Excutive Committe, JUNE 2001. AM J RESPIR CRIT CAR MED 165(2):277-304.ERRATUM IN: AM J RESPIR CRIT CARE MED.166:426. |
[6] | Cacoub P, Poynard P, Ghillani P, ET AL., (1999): Extrahepatic Manifestations Of Chronic hepatitis C Virus Infection. Multivirc Group. Multidepartment Virus C Arthrtis Rhum; 42(10):2204-12. |
[7] | Cacoub P, Renue C, Rosenthal E E, ET AL; (2000), Exrahepatic Manifestations Associated With hepatitis C Virus Infection .a prospective Multicenter Study of 321 Patients. the GERMIVIC. Medicine.;79(1):47-56. |
[8] | Charles. E.D. and Dustin. L.B.; (2009): Hepatitis C., Virus. Induced Cryoglobulinemia. KIDNEY INT.:76(8);818-824. |
[9] | Di Bisceglie A and Hoofnagle J., (2002): Optimal therapy of hepatitis C. Hepatology; 36: (Suppl 1): S; 121 - 127. |
[10] | EL-Zanaty, Fatma Ann. Way, (2009) Egypt Demographic and Health Survey 2008 , Ministry of Health, EL-Zanaty and Associates, and Macrointernational, Cairo, Egypt. |
[11] | El-Zayadi A, Abaza H, Shawky S, et al., (2001): Prevalence and epidemiological features of hepatocellular carcinoma in Egypt-a single centre experience. Hepatol Res; 19: 170 - 179. |
[12] | Erturk A, Capan N, Dursun A, et al., (2006): Pulmonary alterations in patients with chronic HCV infection. Digestive and liver diseases; 38: 673 - 676. |
[13] | Ferri C and Mascia MT., (2006): Cryoglobulinemic vasculitis. Curr Opin Rheumatol; 18: 54 - 63. |
[14] | Flaherty K, Toews G, Travis W et al, (2002): Clinical significance of histological classification of Idiopathic interstitial pneumonia. Eur Respir J; 19:275 - 283. |
[15] | Gumber S and Chopra S., (1995): HCV: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med; 123: 615 - 620. |
[16] | Haddad J, Deny P, Munz-Gotheil C et al., (1992): Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet; 339: 321 - 323. |
[17] | Hunninghake K, Lynch D, Galvin J et al., (2003): Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest, 124:1215-1223. |
[18] | Johnson R, Gretch D, Yamabe H et al., (1993): Membrano-proliferative GN associated with hepatitis C virus infection. N Engl J Med; 328: 465 - 470. |
[19] | Knapp R and Miller M., (1992): Clinical epidemiology and biostatistics. Baltimore: Williams and Wilkins; Malvern, Pa. : Harwal Pub; Co., c. |
[20] | Kula-M, Gulmez-I, Tutus-A, et.al; (2002): Impaired Lung Epithelial Permeability in Hepatitis C Virus Antibody Positive Patients Detected by 99mTc-DTPA Aerosol Scintegraphy Nucl Med. Commun ;23(5):441-6. |
[21] | Moorman J, Fitzgerald S and Prayther D B., (2005): Induction of p38 and g C1qR-dependent IL-8 expression in pulmonary fibroblasts by soluble HC core protein. Respiratory Research; 6: 105 - 109. |
[22] | Okutan O, Kartaloglu Z, Ilvan A et al., (2004): Values of HRCT and pulmonary function tests in managements of patients with CHC virus infection. World J Gastroenterol, 1: 10: 381 - 384. |
[23] | Raghu G, Weycker D, Edelsberg J et al., (2006): Incidence and prevalence of idiopathic pulmonary fibrosis. Am. J Respir Crit Care Med 174:810 - 816. |
[24] | Ramos-Casals M, Stone J, Cid MC et al., (2012): The Cryoglobulinemia. Lancet; 379 (9813) 348 - 360. |
[25] | Saleh.MA, EL-Alafy H, Arafa-MM, et.al; (2014): Association Between HCV Induced Mixed Cryoglobulnemia and Pulmonary Affection: The Role of TNF-Alfa in The Pathogenisis of Pulmonary-Changes. Egyptian Journal of Chest Diseases and Tubercul OSIS;63,259-265. |
[26] | SENE D, GHILLANI-DALBIN P, LIMAL N ET.AL, (2006): Anti-Cyclic Citrullnated Peptide Antibodies in HCV Associated Rheumatological Manifestations and Sjogren’s Syndrome Ann Rheuma Dis;65:394-397. |
[27] | Shaker M, Abdella H, Hetta, et al., (2010): Interstitial pulmonary changes in patients with hepatitis C-related chronic liver disease. Arab Journal of Gastroenterology; 11 (3) 136-140. |
[28] | Stevenova-Petrova DV, Tzveetanska AH, Naumova EJ et.al. (2007): Chronic hepatitis C Virus Infection: Prevalence of Extrahepatic Manifestations and Association With Cryoglobulinemia in Bulgarian Patients. J Gastroenterol; 13:6518-6528. |
[29] | Stardar DB, (2004): Diagnosis, Management, And Treatment of hepatitis C –AASLD Practice Guidline.39:1147-1171. |
[30] | Zignego A, Ferri C, Monti M et al., (2007): Hepatitis C virus as a lymphotropic agent; evidences and pathogenetic implications. Clin Exp Rheumatol; 13: 33 - 37. |
[31] | Ziser A, Plevak DJ, Wiesner RH, ET AL, (1999): Morbidity and Mortality in Cirrhotic Patients Undergoing Anesthea and Surgery. Anesthesiology;90(1):42-53. |
[32] | Yamabe H, Johnson RJ, Gretch DR et.al (1995): Membrano-proliferative GN associated with HCV infection responsive to IFN a. Am J Kidney Dis; 25: 67-69. |